The worth per dose of the Russian coronavirus vaccine Sputnik V can be a lot decrease than that of the vaccines of US drug giants Pfizer and Moderna, mentioned the Russian vaccine’s official Twitter account on Sunday.
“Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of USD 39 and USD 50-USD 74 per person. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines. The price of Sputnik V will be much lower,” the official account mentioned.
Translating pharma lingo: the introduced worth of Pfizer of $19.50 and Moderna of $25-$37 per dose really means their worth of $39 and $50-$74 per particular person. Two doses are required per particular person for the Pfizer, Sputnik V and Moderna vaccines. The worth of Sputnik V can be a lot decrease. https://t.co/nr1C7RBdZB
— Sputnik V (@sputnikvaccine) November 22, 2020
Russia grew to become the primary nation to register the world’s first COVID-19 vaccine on August 11. Sputnik V was developed by the Gamaleya National Research Centre for Epidemiology and Microbiology of the Russian Healthcare Ministry.
On November 11, Russia had mentioned that its vaccine Sputnik V is 92 per cent efficient at defending individuals from COVID-19 in accordance with the primary interim evaluation.
On November 17, Moderna, in its official assertion, had introduced that the unbiased, U.S. NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase three examine of mRNA-1273 has knowledgeable Moderna that the trial has met the statistical standards pre-specified within the examine protocol for efficacy, with a vaccine efficacy of 94.5%.
Similarly, on November 18, Pfizer had mentioned that closing outcomes from the late-stage trial of its coronavirus vaccine was discovered to be 95 per cent efficient and had no critical unwanted effects on older individuals.
(Except for the headline, this story has not been edited by NDTV employees and is printed from a syndicated feed.)